相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Characterization of PTPN2 and its use as a biomarker
Stephanie Bussieres-Marmen et al.
METHODS (2014)
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients
Karin Beelen et al.
BREAST CANCER RESEARCH (2014)
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
Karin Beelen et al.
BREAST CANCER RESEARCH (2014)
Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit
Josefine Bostner et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Tamoxifen resistance: From bench to bedside
Marjolein Droog et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
PTP1B and TCPTP - nonredundant phosphatases in insulin signaling and glucose homeostasis
Tony Tiganis
FEBS JOURNAL (2013)
TCPTP Regulates SFK and STAT3 Signaling and Is Lost in Triple-Negative Breast Cancers
Benjamin J. Shields et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials
Elin Karlsson et al.
BREAST CANCER RESEARCH (2013)
Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?
Karin Beelen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia
Maria Kleppe et al.
BLOOD (2011)
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
Mahmoud R. Khoshnoud et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Akt signalling in health and disease
Ingeborg Hers et al.
CELLULAR SIGNALLING (2011)
High-Resolution Genomic Analysis of the 11q13 Amplicon in Breast Cancers Identifies Synergy with 8p12 Amplification, Involving the mTOR Targets S6K2 and 4EBP1
Elin Karlsson et al.
GENES CHROMOSOMES & CANCER (2011)
Protein tyrosine phosphatase N2 regulates TNFα- induced signalling and cytokine secretion in human intestinal epithelial cells
Michael Scharl et al.
GUT (2011)
Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma
Maria Kleppe et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer
Todd W. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
Todd W. Miller et al.
BREAST CANCER RESEARCH (2011)
Loss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion
Michael Scharl et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells
Jasminka Omerovic et al.
BIOCHEMICAL JOURNAL (2010)
Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
Elina Mattila et al.
BMC CANCER (2010)
Loss, mutation and deregulation of L3MBTL4 in breast cancers
Lynda Addou-Klouche et al.
MOLECULAR CANCER (2010)
Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
Maria Kleppe et al.
NATURE GENETICS (2010)
Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma
Chun-Feng Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Cell cycle-dependent regulation of SFK, JAK1 and STAT3 signalling by the protein tyrosine phosphatase TCPTP
Ben J. Shields et al.
CELL CYCLE (2008)
The protein tyrosine phosphatase TCPTP controls VEGFR2 signalling
Elina Mattila et al.
JOURNAL OF CELL SCIENCE (2008)
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer
J. Bostner et al.
ONCOGENE (2007)
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
Gizeh Perez-Tenorio et al.
CLINICAL CANCER RESEARCH (2007)
Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer
Lars E. Rutqvist et al.
ACTA ONCOLOGICA (2007)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
Lisa M. McShane et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients
Lars E. Rutqvist et al.
ACTA ONCOLOGICA (2006)
Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases:: From diabetes, obesity to cell cycle, and cancer
N Dubé et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP
S Galic et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients
MS Askmalm et al.
ACTA ONCOLOGICA (2004)
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance
R Schiff et al.
CLINICAL CANCER RESEARCH (2004)
Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP
S Galic et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Amplification of HSD17B1 and ERBB2 in primary breast cancer
C Gunnarsson et al.
ONCOGENE (2003)
Akt kinases in breast cancer and the results of adjuvant therapy
O Stal et al.
BREAST CANCER RESEARCH (2003)
Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients
G Pérez-Tenorio et al.
BRITISH JOURNAL OF CANCER (2002)
Protein tyrosine phosphatases: Dephosphorylating the epidermal growth factor receptor
T Tiganis
IUBMB LIFE (2002)
The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor
M Klingler-Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression
K Kittiniyom et al.
BREAST CANCER RESEARCH (2001)
分享论文
